Vyera Pharmaceuticals Revenue, Growth & Competitor Profile

DBA TURING PHARMACEUTICALS LLC

Company Profile & Annual Report for Vyera Pharmaceuticals

Access the complete profile.

Vyera Pharmaceuticals Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing
Address	600 3rd Avenue 19th Floor New York, NY 10016

Note: Revenues for privately held companies are statistical evaluations.


Vyera Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Vyera Pharmaceuticals's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Vyera Pharmaceuticals is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Vyera Pharmaceuticals Annual Revenue and Growth Rate

Vyera Pharmaceuticals	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$10 - $100 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Vyera Pharmaceuticals's revenues are gauged from an analysis of company filings.

Vyera Pharmaceuticals's Income Statement (based on Industry Averages)

Vyera Pharmaceuticals P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Market Share of Vyera Pharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as Vyera Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Vyera Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
PFIZER	New York, NY	100
SUMITOVANT BIOPHARMA	New York, NY	3
ROIVANT SCIENCES	New York, NY	2
TERRASCEND USA	New York, NY	1
KADMON HOLDINGS	New York, NY	0
CALLIDITAS NA ENTERPRISES	New York, NY	0

Other Companies at 600 3rd Avenue, New York NY

Company	Headquarters	Revenue ($ MM)
NEW YORK CITY FOOTBALL CLUB LLC.	New York, NY	100
DATACRATIC US	New York, NY	0

Future Competition: Vyera Pharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as Vyera Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)